Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
about
Statins for the primary prevention of cardiovascular diseaseStatins for the primary prevention of cardiovascular diseaseInterventions to improve adherence to lipid lowering medicationInterventions to improve adherence to lipid lowering medicationUse of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trialsThe exclusion of patients with chronic kidney disease from clinical trials in coronary artery diseaseInterventions to improve adherence to lipid-lowering medication.Patient tolerance and acceptance of colesevelam hydrochloride: focus on type-2 diabetes mellitus.Meta-analysis of interventions to improve drug adherence in patients with hyperlipidemia.Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy.High persistence of statin use in a Danish population: compliance study 1993-1998.Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndromeAssociation between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease.Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention.Over-the-counter fish oil use in a county hospital: Medication use evaluation and efficacy analysisThe contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment.Poor adherence with hypolipidemic drugs: a lost opportunity.Determinants of non-compliance with lipid-lowering therapy in hyperlipidemic patients.Risk factors for coronary heart disease in 55- and 35-year-old men and women in Sweden and Estonia.Dietary administration of colesevelam hydrochloride does not affect fertility or reproductive performance in rats.
P2860
Q24201513-C3FCB0CA-A106-4869-A8F2-0EBD25F5A764Q24234813-47EFC556-08F0-4181-9E4B-2D50D06CA925Q24236817-04C1FE5C-6C96-4E66-95A0-1D428FD76EAAQ24245739-2B67D6E1-626E-490E-9A49-B00AB510C633Q34065021-35114C3E-4C31-4045-A039-841A091E3673Q34175429-9B2C2BDC-278F-4FC4-98A1-2047EACE6FE7Q34547763-DC326437-CE3C-4DFA-B5C3-F51C206EAB5EQ34976294-5150BEA9-EE6E-4701-8AAC-4849F1D83196Q35043379-C5F0B92F-45CA-4BB7-9D6F-01D0DBF805C2Q35640331-885B4C51-BF3D-4FF8-94A1-58C813627AEBQ35803620-272007AC-C55B-480D-A9C6-5B208F37BDEAQ35825711-A257E96B-BDF7-4568-AA8F-84D9E6A035A0Q35826483-69414C9B-5E88-4458-A575-42BBCAF38E19Q35826989-005FE0F5-B246-498F-AF16-B3AF6C44E10BQ36561806-FAA99BF3-3E7A-4536-B506-F0F4A14484D5Q37107485-0372B389-6D85-4E89-AF18-7C7EBB8EB515Q43605177-D5D247E4-1D70-404D-988C-7149503677DFQ44236160-00AB9A52-845C-4555-8EB0-7A0D73418224Q44242893-AAC6519A-421B-456E-9530-535281BB5B8DQ46375204-B57589F3-F60D-4C2F-9B64-D4BADD73CD80
P2860
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Compliance with and efficacy o ...... ipid-lowering in primary care.
@en
Compliance with and efficacy o ...... ipid-lowering in primary care.
@nl
type
label
Compliance with and efficacy o ...... ipid-lowering in primary care.
@en
Compliance with and efficacy o ...... ipid-lowering in primary care.
@nl
prefLabel
Compliance with and efficacy o ...... ipid-lowering in primary care.
@en
Compliance with and efficacy o ...... ipid-lowering in primary care.
@nl
P2093
P2860
P1476
Compliance with and efficacy o ...... ipid-lowering in primary care.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2796.1998.00294.X
P407
P577
1998-05-01T00:00:00Z